Overview

Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Literature regarding the effect of food on the pharmacokinetic (PK) profile of enteric-coated mycophenolate sodium combined with tacrolimus and corticosteroid withdrawal is lacking. The objective of this study is to identify pharmacokinetic variables of mycophenolate sodium (Myfortic®) in the fed and fasting state in stable renal transplant patients on tacrolimus in combination with a rapid steroid withdrawal protocol.
Phase:
Phase 4
Details
Lead Sponsor:
University of Utah
Treatments:
Mycophenolate mofetil
Mycophenolic Acid
Tacrolimus